{"title":"基于多光谱和分子动力学研究5种黄酮类化合物与PD-L1的相互作用机制。","authors":"Yijie Cai , Yijun Tu , Hong Cheng , Jianqing Yu","doi":"10.1016/j.cbi.2025.111741","DOIUrl":null,"url":null,"abstract":"<div><div>PD-L1 is an important protein overexpressed in various types of cancer. Flavonoids as common antioxidants have extensive bioactivities. In this study, the interaction mechanism and the structure-activity relationship between the five flavonoids and extracellular domain of PD-L1 (PD-L1-ECD) were investigated using integrated spectroscopy and computational simulation. Fluorescence spectra showed that the quenching mechanisms of the interaction between the five flavonoids and PD-L1-ECD were static quenching. Circular dichroism (CD) spectra showed that the five flavonoids caused conformational changes of PD-L1-ECD. Computational simulation data showed the different binding patterns between five flavonoids and PD-L1-ECD. The binding affinity of the five flavonoids which affected by hydrogenation of C2=C3 bond and the substitution of C3 decreased in the following order: luteolin > kaempferol > spinacetin > axillarin > hesperetin. This study suggested that five flavonoids could bind to the PD-L1-ECD, thereby establishing a foundation for developing these compounds as small-molecule PD-L1 inhibitors. Subsequent structure-activity relationship was studied based on distinct binding modes and binding affinity, and it will contribute to structural modifications to optimize therapeutic potency.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"421 ","pages":"Article 111741"},"PeriodicalIF":5.4000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Investigating the interaction mechanism of five flavonoids and PD-L1 based on multi-spectroscopy and molecular dynamics\",\"authors\":\"Yijie Cai , Yijun Tu , Hong Cheng , Jianqing Yu\",\"doi\":\"10.1016/j.cbi.2025.111741\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>PD-L1 is an important protein overexpressed in various types of cancer. Flavonoids as common antioxidants have extensive bioactivities. In this study, the interaction mechanism and the structure-activity relationship between the five flavonoids and extracellular domain of PD-L1 (PD-L1-ECD) were investigated using integrated spectroscopy and computational simulation. Fluorescence spectra showed that the quenching mechanisms of the interaction between the five flavonoids and PD-L1-ECD were static quenching. Circular dichroism (CD) spectra showed that the five flavonoids caused conformational changes of PD-L1-ECD. Computational simulation data showed the different binding patterns between five flavonoids and PD-L1-ECD. The binding affinity of the five flavonoids which affected by hydrogenation of C2=C3 bond and the substitution of C3 decreased in the following order: luteolin > kaempferol > spinacetin > axillarin > hesperetin. This study suggested that five flavonoids could bind to the PD-L1-ECD, thereby establishing a foundation for developing these compounds as small-molecule PD-L1 inhibitors. Subsequent structure-activity relationship was studied based on distinct binding modes and binding affinity, and it will contribute to structural modifications to optimize therapeutic potency.</div></div>\",\"PeriodicalId\":274,\"journal\":{\"name\":\"Chemico-Biological Interactions\",\"volume\":\"421 \",\"pages\":\"Article 111741\"},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chemico-Biological Interactions\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0009279725003710\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemico-Biological Interactions","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009279725003710","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Investigating the interaction mechanism of five flavonoids and PD-L1 based on multi-spectroscopy and molecular dynamics
PD-L1 is an important protein overexpressed in various types of cancer. Flavonoids as common antioxidants have extensive bioactivities. In this study, the interaction mechanism and the structure-activity relationship between the five flavonoids and extracellular domain of PD-L1 (PD-L1-ECD) were investigated using integrated spectroscopy and computational simulation. Fluorescence spectra showed that the quenching mechanisms of the interaction between the five flavonoids and PD-L1-ECD were static quenching. Circular dichroism (CD) spectra showed that the five flavonoids caused conformational changes of PD-L1-ECD. Computational simulation data showed the different binding patterns between five flavonoids and PD-L1-ECD. The binding affinity of the five flavonoids which affected by hydrogenation of C2=C3 bond and the substitution of C3 decreased in the following order: luteolin > kaempferol > spinacetin > axillarin > hesperetin. This study suggested that five flavonoids could bind to the PD-L1-ECD, thereby establishing a foundation for developing these compounds as small-molecule PD-L1 inhibitors. Subsequent structure-activity relationship was studied based on distinct binding modes and binding affinity, and it will contribute to structural modifications to optimize therapeutic potency.
期刊介绍:
Chemico-Biological Interactions publishes research reports and review articles that examine the molecular, cellular, and/or biochemical basis of toxicologically relevant outcomes. Special emphasis is placed on toxicological mechanisms associated with interactions between chemicals and biological systems. Outcomes may include all traditional endpoints caused by synthetic or naturally occurring chemicals, both in vivo and in vitro. Endpoints of interest include, but are not limited to carcinogenesis, mutagenesis, respiratory toxicology, neurotoxicology, reproductive and developmental toxicology, and immunotoxicology.